Cited by 29Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchAdvanced Glycation End Products research

Racial differences in and prognostic value of biomarkers of hyperglycemia

Open access
Parrinello, Christina M., Sharrett, A. Richey, Maruthur, Nisa M., Bergenstal, Richard M., Grams, Morgan E., Coresh, Josef, Selvin, Elizabeth·2016·Diabetes Care

Abstract

OBJECTIVE: We compared levels and associations of traditional (fasting glucose, HbA1c) and nontraditional (fructosamine, glycated albumin, and 1,5-anhydroglucitol [1,5-AG]) biomarkers of hyperglycemia with incident cardiovascular disease (CVD), incident end-stage renal disease (ESRD), and prevalent retinopathy in black and white adults. RESEARCH DESIGN AND METHODS: We included 10,373 participants without (8,096 white, 2,277 black) and 727 with diagnosed diabetes (425 white, 302 black) from the Atherosclerosis Risk in Communities (ARIC) Study. We used Cox proportional hazards models to compare hazards ratios of CVD and ESRD among blacks and whites from baseline (1990–1992) through 2012. We compared the odds ratios (from logistic regression) of retinopathy among blacks and whites. We tested for the interaction of each biomarker with race. RESULTS: Median values of biomarkers were higher among blacks versus whites (all P < 0.001). Relative risks for each biomarker with incident CVD and ESRD, and odds ratios for each biomarker with prevalent retinopathy, were similar by race (all P values for interaction by race >0.10). CONCLUSIONS: The prognostic value of HbA1c, fructosamine, glycated albumin, and 1,5-AG with incident CVD, incident ESRD, and prevalent retinopathy were similar by race. Our results support similar interpretation of HbA1c and nontraditional biomarkers of hyperglycemia among black and whites with respect to long-term complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc15-1360

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study among races showed that all measures of glycemia, including HbA1c, fructosamine, and glycated albumin, were on average higher among Black participants compared with White participants, and that the measures were similarly associated with risk of nephropathy, retinopathy, and cardiovascular disease in the different races.

    “In addition, a study among races showed that all measures of glycemia, including HbA 1c , fructosamine, and glycated albumin, were on average higher among Black participants compared with White participants, and that the measures were similarly associated with risk of nephropathy, retinopathy, and cardiovascular disease (CVD) in the different races (340).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [340]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • The consistency of glycemic measurements within races and the similar relationship of each glycemic measurement with complications in Black compared with White populations suggests that higher HbA1c measurements in Black populations reflects, at least in part, higher glycemic exposure and not just a difference in the relationship between mean glycemia and HbA1c levels.

    “The consistency of glycemic measurements within races and the similar relationship of each glycemic measurement with complications in Black compared with White populations suggests that higher HbA 1c measurements in Black populations reflects, at least in part, higher glycemic exposure and not just a difference in the relationship between mean glycemia and HbA 1c levels.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 47 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Parrinello, C. M., Sharrett, A. R., Maruthur, N. M., Bergenstal, R. M., Grams, M. E., Coresh, J., & Selvin, E.
Affiliations
  • Johns Hopkins University (US)
  • Park Nicollet Health Services (US)
Corresponding author
Selvin, Elizabeth
Venue
Diabetes Care
Published
2015-12-17
Volume
39
Issue
4
Pages
589-595
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2206827451
Cited by
29
References
47
Citations by year
2026: 4 · 2025: 2 · 2024: 3 · 2023: 2 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 2
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIH/NHLBI (T32HL007024)
  • NIH/NIDDK (R01DK089174, K24DK106414, HHSN268201100005C)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
racial differences, black-white disparities, HbA1c, fructosamine, glycated albumin, 1,5-anhydroglucitol, cardiovascular disease, end-stage renal disease, diabetic retinopathy, diabetes complications, prognostic value, Atherosclerosis Risk in Communities Study
MeSH terms
Glycated Serum Albumin, Blood Glucose, Cardiovascular Diseases, Deoxyglucose, Diabetes Mellitus, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Kidney Failure, Chronic, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Serum Albumin, Biomarkers, Body Mass Index, Incidence, Proportional Hazards Models, Glycation End Products, Advanced, Fructosamine, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review